Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-09

Clinical Trial Update: Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 trial of nivolumab and ipilimumab with chemotherapy for stage IV non-small cell lung cancer with brain metastases is currently active and not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ipilimumab (ipilimumab)
  • nivolumab (nivolumab)

Snippet

Sponsor: Fundación GECP | Conditions: Non Small Cell Lung Cancer, Brain Metastases, Adult | Phase 2 | Status: ACTIVE_NOT_RECRUITING